The commercial value of a treatment programme comes from the whole system: selecting chemistry on evidence, delivering it consistently, measuring the response and revisiting settings when conditions change.
Results and savings depend on the site. Critical Elixirs does not publish a universal return claim; we scope the opportunity from operating data and testing.
Related